Advantagene's mission is to apply biotechnology advancements to develop drugs that provide better health, better cost and better quality of life for cancer patients and their families.
Advantagene is focused on preventing the recurrence and progression of cancer. As cancer inevitably escapes the current treatment options, its recurrence and progression is the largest cause of patient morbidity and mortality. Continued progress in fighting cancer will require novel therapeutic approaches that improve current care. Advantagene’s cytotoxic immunotherapy has shown promise in this goal.
|Board of Directors|